National Comprehensive Cancer Network

About NCCN

Now Available on! In-Depth Summary of NCCN Policy Summit

Jessica DeMartino, PhD, Manager, Health Policy Programs

On Tuesday, April 2, 2013, the National Comprehensive Cancer Network® (NCCN®) held the NCCN Oncology Policy Summit: Evolving Policy Issues in Oncology – Revisiting Biosimilars and Molecular Testing at the National Press Club in Washington, DC. Stakeholders gathered to examine how biosimilars and molecular testing in oncology, two topics addressed in 2011 by NCCN Work Groups and at NCCN Policy Summits, have changed since 2011. The Summit's agenda included discussion of the current status of these areas, review of the newest guidance documents and regulatory requirements, examination of payer viewpoints and practices, and discussion about where the oncology community is headed on these two important issues. The program, moderated by Clifford Goodman, PhD, of The Lewin Group, consisted of two short presentations and two roundtable discussions with vigorous discussion and audience participation.

An in-depth summary of the Summit is now available on for those who were unable to attend.

For more information about the NCCN Oncology Policy Program, visit